Teva reports seventh straight quarter of growth
The Israeli pharmaceutical company beat the analysts and has again raised 2024 revenue guidance, this time to $16.1-16.5 billion.
Nova led the gains today after posting strong third quarter results but Teva fell again.
Wed: Trump win lifts TA 35 Index to new recordNICE and Tower led he market higher today but Teva fell despite strong Q3 results.
Teva reports seventh straight quarter of growth
The Israeli pharmaceutical company beat the analysts and has again raised 2024 revenue guidance, this time to $16.1-16.5 billion.
Trump victory strengthens shekel and boosts TASE
After Donald Trump's victory in the US presidential election the Tel Aviv Stock Exchange (TASE) indices have climbed to new records while the shekel is appreciating.
Trump win seen generally positive for markets
Energy, defense, and pharmaceuticals stocks, plus cryptocurrencies, are seen as the big gainers.